Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 16617

Known as: CGS-16617 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

libenzapril

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers
SummaryA new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 16617, has been evaluated in normotensive subjects… Expand
2004
2004
Intra- and Intersubject Variability: Mixed-Effects Statistical Analysis of Repeated Doses of an Angiotensin Converting Enzyme Inhibitor, CGS 16617
The intrasubject and intersubject variabilities for CGS 16617, an angiotensin converting enzyme inhibitor, were evaluated in an… Expand
Highly Cited
1991
Highly Cited
1991
Cardiac and Aortic Effects of Angiotensin Converting Enzyme Inhibitors
The effects of six angiotensin converting enzyme inhibitors (captopril, CGS-16617, cilazapril, enalapril, utibapril, and… Expand
  • table 1
  • table 2
  • table 4
  • table 5
1990
1990
Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats.
The effects of angiotensin-converting enzyme inhibitors on cardiovascular mass and function were measured in three groups of 22… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
1989
1989
Physiological disposition of CGS 16617 in rat, dog, and man.
The disposition and metabolism of CGS 16617 (3-[(5-amino-1-carboxy-1S-pentyl)amino],2,3,4,5-tetrahydro-2-oxo-3S-1H-1… Expand
1988
1988
Effect of Food on the Bioavailability of Pentopril, an Angiotensin‐Converting‐Enzyme Inhibitor, in Healthy Subjects
Pentopril (CGS 13945) was administered in 125‐mg capsules to eight healthy men on two occasions according to a randomized… Expand
1988
1988
Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat.
The present study was designed to examine the effects of two new angiotensin-converting enzyme (ACE) inhibitors, CGS 14831 and… Expand
1988
1988
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617.
  • N. Levens
  • Archives internationales de pharmacodynamie et de…
  • 1988
    • Corpus ID: 30424246
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617 were evaluated in anesthetized dogs. Intravenous… Expand
1987
1987
Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
The effect of a specific inhibitor of thromboxane (Tx) A2 synthesis, CGS-13080, a new angiotensin converting enzyme inhibitor… Expand
1987
1987
Additive Beneficial Effects of Two Inhibitors of Vasoconstrictor Mediators in Acute Myocardial Ischemia 1
Abstract A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-12970, a new angiotensin-converting enzyme (ACE) inhibitor… Expand
  • figure 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE